scholarly journals Physiotherapist-led suprascapular nerve blocks for persistent shoulder pain: Evaluation of a new service in the UK

2017 ◽  
Vol 16 (1) ◽  
pp. 214-221
Author(s):  
E. Salt ◽  
D. A. van der Windt ◽  
L. Chesterton ◽  
F. Mainwaring ◽  
N. Ashwood ◽  
...  
Keyword(s):  
Shoulder Pain ◽  
Suprascapular Nerve ◽  
Nerve Blocks ◽  
Pain Evaluation ◽  
The Uk

scholarly journals Comparative Effectiveness of Injection Therapies for Hemiplegic Shoulder Pain in Stroke: A Systematic Review and Network Meta-Analysis

2021 ◽  
Vol 14 (8) ◽  
pp. 788
Author(s):  
Yi-Hsiang Chiu ◽  
Ke-Vin Chang ◽  
Wei-Ting Wu ◽  
Po-Cheng Hsu ◽  
Levent Özçakar
Keyword(s):  
Systematic Review ◽  
Shoulder Pain ◽  
Comparative Effectiveness ◽  
Treatment Effectiveness ◽  
Weighted Mean Difference ◽  
Meta Analysis ◽  
Suprascapular Nerve ◽  
Nerve Blocks ◽  
Randomized Controlled ◽  
Registration Number

Hemiplegic shoulder pain (HSP) hampers post-stroke functional recovery and is not well managed with conservative treatments. This systematic review aimed to examine the various injection therapies for HSP and investigate their effectiveness at different time points. The protocol of this meta-analysis was registered on INPLASY with a registration number of INPLASY202180010. PubMed, EMBASE, and Scopus were searched from their inception to 4 August 2021 for the clinical studies investigating comparative effectiveness of different injection regimens for treating hemiplegic shoulder pain in patients with stroke. The primary outcome was the weighted mean difference (WMD) on the visual analog scale (VAS) of pain reduction in the fourth-week and between the fourth and twenty-fourth weeks. Ranking probabilities of the WMD for each treatment were obtained using simulations. Seventeen studies with 595 participants were included. The network meta-analysis showed that at the fourth-week, intra-muscular botulinum toxin (BoNT) injections and suprascapular nerve blocks (SSNB) were superior to a placebo, with WMDs of 1.55 (95% CI, 0.09 to 3.01) and 1.44 (95% CI, 0.07 to 2.80), respectively. SSNB possessed the highest probability (53.3%) and appeared to be the best treatment in the fourth-week, followed by intra-muscular BoNT injections (42.6%). Intramuscular BoNT injections were better than the placebo, with a WMD of 1.57 (95% CI, 0.30 to 2.84) between the 4th and 24th weeks. Intramuscular BoNT injections had the highest probability (79.8%) as the best treatment between the 4th and 24th weeks. SSNB was likely to rank first in relieving HSP at the fourth post-treatment week, whereas intra-muscular BoNT injections had the highest probability to achieve the best treatment effectiveness in the post-injection period between the fourth and twenty-fourth weeks. However, as some of the included studies used a non-randomized controlled design, more randomized controlled trials are needed in the future to validate and better understand the short- and long-term efficacy of different injection therapies for management of HSP.

scholarly journals Neuromodulation of the Suprascapular Nerve

2016 ◽  
Vol 1;19 (1;1) ◽  
pp. E235-E239
Author(s):  
Erkan Kurt
Keyword(s):  
Peripheral Nerve ◽  
Shoulder Pain ◽  
Excellent Result ◽  
Treatment Options ◽  
Treatment Protocol ◽  
Suprascapular Nerve ◽  
Orthopedic Procedures ◽  
Invasive Treatment ◽  
Nerve Blocks ◽  
Shoulder Region

Chronic intractable shoulder pain (CISP) is defined as shoulder pain which is present for longer than 6 months and does not respond to standard treatments like medication, physical therapy, rehabilitation, selective nerve blocks and local infiltrations, or orthopedic procedures. The etiology of CISP may be very diverse, varying from many orthopedic conditions to non-orthopedic conditions. The fact that the suprascapular nerve is one of the most important nerves supplying the shoulder region makes this nerve an interesting target in treating patients suffering shoulder pain. Invasive treatment options are peripheral nerve blocks, temporary electrical stimulation, and neurostimulation. To our best knowledge, thus far there are only a few reports describing the technique of permanent neurostimulation of the suprascapular nerve. In this article we present a patient suffering shoulder pain after she underwent surgery for cervical stenosis. After a step by step treatment protocol was done, we finally offered her trial stimulation of the suprascapular nerve. A single quad lead was implanted via a posterior approach under fluoroscopic and ultrasound guidance. Two weeks after successful stimulation, we implanted a permanent neuromodulation system. Permanent neurostimulation of the suprascapular nerve and its end branches may be a new interesting target in treating patients suffering shoulder pain due to various etiologies. In our patient the followup period is 9 months with an excellent result in pain relief, we observed no complications thus far, especially no dislocation or breakage of the lead. In this report, literature on this subject is reviewed, and our technique is well documented with additional anatomical illustrations. Key words: Suprascapular nerve, shoulder pain, peripheral nerve stimulation, neuromodulation, neurostimulation, chronic pain

scholarly journals ULTRA-SOUND GUIDED SUPRASCAPULAR NERVE BLOCK IN HEMIPLEGIC SHOULDER PAIN

2018 ◽  
Vol 5 (46) ◽  
pp. 3228-3232
Author(s):  
Swapnil Pramod Sonune ◽  
Anil Kumar Gaur ◽  
Shefali Gupta
Keyword(s):  
Shoulder Pain ◽  
Nerve Block ◽  
Suprascapular Nerve ◽  
Ultra Sound ◽  
Suprascapular Nerve Block

scholarly journals Effectiveness of Suprascapular Nerve Block in the Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 12 ◽  
Author(s):  
Yajing Hou ◽  
Yong Wang ◽  
Xiaojing Sun ◽  
Yake Lou ◽  
Ying Yu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Shoulder Pain ◽  
Nerve Block ◽  
External Rotation ◽  
Meta Analysis ◽  
Suprascapular Nerve ◽  
Cochrane Library ◽  
Control Group ◽  
Suprascapular Nerve Block ◽  
Secondary Endpoints

Purpose: We aimed to investigate the effectiveness of suprascapular nerve block (SSNB) in patients with hemiplegic shoulder pain (HSP).Background: SSNB is widely used in various shoulder pains, but whether it is effective in HSP remains unknown.Methods: PubMed, Cochrane Library, and Embase databases were searched to identify potential citations. Randomized controlled trials meeting the eligible criteria were included in our analysis. The primary endpoint was Visual Analog Scale (VAS) with a maximum value of 100 and a minimum value of 0. Secondary endpoints were passive range of motion (PROM) that pain starts, and the PROM mainly included abduction, flexion, and external rotation. In addition, the upper extremity Fugl-Meyer assessment (FMA) was also included in our secondary endpoints.Results: Eight studies with 281 patients were included in our analysis. For VAS, there was no obvious difference between SSNB group and control group regardless of the follow-up period (<4 weeks or ≥4 weeks), which were −6.62 (−15.76, 2.53; p = 0.16) and 1.78 (−16.18, 19.74; p = 0.85). For shoulder function, the PROM of abduction, flexion, and external rotation was similar between groups. However, motor function indicator FMA is lower in SSNB control than that in control group, with a mean difference (and 95% CI) of −2.59 (−4.52, −0.66; p = 0.008).Conclusion: SSNB is an effective way for HSP patients.Systematic Review Registration: Registration ID: CRD42021252429.

scholarly journals Effects of ultrasound-guided suprascapular nerve pulsed radiofrequency on chronic shoulder pain

2018 ◽  
Vol 20 (4) ◽  
pp. 461 ◽  
Author(s):  
Tolga Ergonenc ◽  
Serbulent Gokhan Beyaz
Keyword(s):  
Shoulder Pain ◽  
External Rotation ◽  
Adhesive Capsulitis ◽  
Suprascapular Nerve ◽  
Pulsed Radiofrequency ◽  
Ultrasound Guided ◽  
Duration Of Action ◽  
Vas Score ◽  
Long Duration ◽  
Chronic Shoulder Pain

Aim: Pulsed radiofrequency (PRF) therapy has become increasingly popular in the treatment of chronic shoulder pain due to its long duration of action and non-destructive method. The aim of the study was to reveal the effects of PRF therapy of the suprascapular nerve (SSN) under ultrasound guidance (UG) in patients with chronic shoulder pain on both shoulder pain and function.Material and methods: This study included 74 patients diagnosed with at least one of the following: adhesive capsulitis, rotator cuff syndrome and impingement syndrome of shoulder. The PRF therapy of the SSN under UG was performed in those patients with a reduction of 50% or more Visual Analog Scale (VAS) score and those that reported healing in the active range of motion (AROM) in the diagnostic SSN block. The resting, motion and sleeping shoulder pain assessments of the patients were done with VAS score. The shoulder joint function was assessed with the Shoulder Pain and Disability Index (SPADI) questionnaire and the AROM of the joint was measured using a goniometer.Results: In 70 of the 74 patients a 50% or more reduction was found in the VAS score with diagnostic SSN block. After the PRF therapy of the SSN, the 15thday, 1st month, 3rd month, and 6th month follow-up VAS averages, SPADI averages and the flexion, internal rotation, external rotation, and abduction values were statistically significantly lower than the baseline values (p<0.05).Conclusion: This study is the largest series in the literature evaluating the efficacy of PRF therapy of the SSN under UG and has shown that pain canbe controlled quickly, for a long period of time, using ultrasound guided PRF therapy of the SSN in chronic shoulder pain.

Efficacy and safety of ultrasound-guided suprascapular nerve block in patients with chronic shoulder pain☆

2013 ◽  
Vol 41 (2) ◽  
pp. 104-108
Author(s):  
Mario Andrés Arcila Lotero ◽  
Roberto Carlo Rivera Díaz ◽  
Daniel Campuzano Escobar ◽  
María Adelaida Mejía Aguilar ◽  
Sandra Milena Martínez Ramírez
Keyword(s):  
Shoulder Pain ◽  
Nerve Block ◽  
Suprascapular Nerve ◽  
Efficacy And Safety ◽  
Ultrasound Guided ◽  
Suprascapular Nerve Block ◽  
Chronic Shoulder Pain

A case series of suprascapular nerve block (with an historical comparator) for shoulder pain in motor neurone disease

2020 ◽  
Vol 34 (8) ◽  
pp. 1127-1133
Author(s):  
E Michael Shanahan ◽  
Karen Glaezter ◽  
Tiffany Gill ◽  
Catherine Hill ◽  
Scott Graf ◽  
...  
Keyword(s):  
Shoulder Pain ◽  
Nerve Block ◽  
Case Series ◽  
Suprascapular Nerve ◽  
Motor Neurone ◽  
Motor Neurone Disease ◽  
Control Group ◽  
Placebo Control ◽  
Time Interval ◽  
Suprascapular Nerve Block

Background: Shoulder pain is a distressing but under-reported and poorly managed symptom in people with motor neurone disease. Objectives: This study aimed to assess the efficacy of suprascapular nerve block for the management of shoulder pain in patients with motor neurone disease. Methods: A total of 27 patients with motor neurone disease and shoulder pain were offered a suprascapular nerve block. Ten of these patients had bilateral shoulder pain and both were injected, making a total of 37 shoulders. The patients were followed up for a total of 3 months, or until death. Shoulder pain was measured using the pain scale (out of 100) of the shoulder pain and disability index and compared with baseline scores and a placebo control group from an earlier study using the same methodology (ACTRN12619000353190). Results: Following the nerve block there was a significant improvement of pain scores from baseline (58.4) at week 1 (20.8, p < 0.000), week 6 (17.6, p < 0.000) and week 12 (30.4, p = 0.001) and a significant improvement compared with the control group across each time interval. Conclusion: Suprascapular nerve block is a safe, effective therapy for patients with chronic shoulder pain.

Sign in / Sign up

Export Citation Format

Share Document